Clear Creek Financial Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$392K Buy
5,822
+20
+0.3% +$1.33K 0.03% 461
2026
Q1
$364K Sell
5,802
-66
-1% -$4.6K 0.03% 459
2025
Q4
$389K Sell
5,868
-1,218
-17% -$78.7K 0.03% 439
2025
Q3
$477K Sell
7,086
-365
-5% -$28.9K 0.04% 374
2025
Q2
$650K Sell
7,451
-561
-7% -$44K 0.06% 307
2025
Q1
$547K Sell
8,012
-41
-0.5% -$3.35K 0.06% 299
2024
Q4
$626K Sell
8,053
-93
-1% -$6.88K 0.07% 257
2024
Q3
$546K Buy
8,146
+5,185
+175% +$426K 0.06% 254
2024
Q2
$336K Buy
2,961
+120
+4% +$15.2K 0.04% 317
2024
Q1
$394K Buy
2,841
+38
+1% +$4.78K 0.05% 282
2023
Q4
$348K Buy
2,803
+25
+0.9% +$2.55K 0.06% 245
2023
Q3
$259K Buy
+2,778
New +$313K 0.05% 255
2021
Q4
Sell
-19,704
Closed -$2.69M 366
2021
Q3
$2.69M Buy
+19,704
New +$2.48M 0.43% 65

Other funds holding DXCM

Clear Creek Financial Management's DXCM Position: Q2 2026 in Review

Clear Creek Financial Management increased its DexCom (DXCM) stake by 0.34% in Q2 2026, buying an estimated $1.33K and bringing the position to 5,822 shares worth $392K. The position accounts for 0.03% of the portfolio, ranked #461.

Clear Creek Financial Management first reported a position in DXCM in Q3 2021 and has held it in 13 quarters since. The position peaked at $2.69M in Q3 2021. 537 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Clear Creek Financial Management held 5,822 shares of DexCom worth $392K as of Q2 2026.
  • Clear Creek Financial Management bought 20 DexCom shares in Q2 2026, an estimated $1.33K.
  • DexCom made up 0.03% of Clear Creek Financial Management's portfolio in Q2 2026, its #461 holding.
  • Clear Creek Financial Management first reported a position in DexCom in Q3 2021 and has held it in 13 quarters since.
  • Clear Creek Financial Management's DexCom position peaked at $2.69M in Q3 2021.
  • 537 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Clear Creek Financial Management's 13F filing for Q2 2026, filed 28 Jul 2026.